Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel (Q46365805)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel |
scientific article |
Statements
1 reference
Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel (English)
1 reference
1 reference
Howard I Scher
1 reference
David B Solit
1 reference
Yuhong She
1 reference
Jose Lobo
1 reference
Neal Rosen
1 reference
Frank M Sirotnak
1 reference
1 March 2005
1 reference
11
1 reference
5
1 reference
1983-1989
1 reference